ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hiroaki Nomori
Takashi Ohtsuka
Tsuguo Naruke
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nomori, H.
Right arrow Articles by Uno, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomori, H.
Right arrow Articles by Uno, K.
Related Collections
Right arrow Lung - cancer
Right arrowRelated Article

Ann Thorac Surg 2005;79:984-988
© 2005 The Society of Thoracic Surgeons

Original article: General thoracic

Visual and Semiquantitative Analyses for F-18 Fluorodeoxyglucose PET Scanning in Pulmonary Nodules 1 cm to 3 cm in Size

Hiroaki Nomori, MD, PhDa,*, Kenichi Watanabe, MDa, Takashi Ohtsuka, MDa, Tsuguo Naruke, MD, PhDa, Keiichi Suemasu, MD, PhDa, Kimiichi Uno, MD, PhDb

a Department of Thoracic Surgery, Saiseikai Central Hospital, Tokyo, Japan
b Nishidai Clinic, Tokyo, Japan

Accepted for publication July 29, 2004.

* Address reprint requests to Dr Nomori, Department of Thoracic Surgery, Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo 108-0073, Japan; (E-mail: hnomori{at}qk9.so-net.ne.jp).

BACKGROUND: While visual assessment is the simplest way to evaluate positron emission tomography (PET) with fluorodeoxyglucose (FDG), faintly positive nodules are often difficult to evaluate. We performed visual and semiquantitative analyses of pulmonary nodules from 1 to 3 cm in size to determine the optimal method of analysis for PET data, especially for faintly positive nodules on visual assessment.

METHODS: Positron emission tomography data were analyzed for 161 pulmonary nodules from 1 to 3 cm in size (108 malignant and 53 benign nodules). On visual assessment, FDG uptake by the nodules was classified into three grades in comparison with mediastinal blood pool, (ie, definitely positive, faintly positive, and negative). In addition, FDG uptake was measured by the standard uptake value (SUV), the contrast ratio to the contralateral lung (CR-lung), and the contrast ratio to the cerebellum (CR-brain). Cut-off values for each variable were determined from receiver operating characteristics (ROC) curves, and the values were 2.5 for the SUV, 0.4 for the CR-lung, and 0.25 for the CR-brain. Nodules with FDG uptake above these cut-off values were defined as positive in each method.

RESULTS: Visual assessment showed definitely positive for 80 nodules (64 malignant and 16 benign), faintly positive for 22 (17 malignant and 5 benign), and negative for 59 nodules (27 malignant and 32 benign). In the 139 nodules that were definitely positive or negative by visual assessment, there were no significant differences of sensitivity and specificity among the four methods (visual assessment, SUV, CR-lung, and CR-brain). In the 17 malignant nodules that were faintly positive, the SUV did not detect any true-positive nodules, but the CR-lung and CR-brain showed 9 and 5 true-positive nodules, respectively, resulting in a significantly higher sensitivity than the SUV (p < 0.001 and p = 0.02, respectively). Fifteen of 17 faintly positive malignant nodules (88%) were histologically well- or moderately-differentiated adenocarcinoma.

CONCLUSIONS: The semiquantitative methods (SUV, CR-lung, and CR-brain) do not improve the efficacy of visual assessment alone for nodules graded as definitely positive or negative. However, faintly positive nodules on visual assessment should be evaluated by the CR-lung or CR-brain rather than the SUV, and are often differentiated adenocarcinomas.


Related Article

INVITED COMMENTARY
Paul De Leyn
Ann. Thorac. Surg. 2005 79: 989. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Nomori, T. Mori, K. Ikeda, K. Kawanaka, S. Shiraishi, K. Katahira, and Y. Yamashita
Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 816 - 822.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. Cronin, B. A. Dwamena, A. M. Kelly, and R. C. Carlos
Solitary Pulmonary Nodules: Meta-analytic Comparison of Cross-sectional Imaging Modalities for Diagnosis of Malignancy
Radiology, March 1, 2008; 246(3): 772 - 782.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti, W. K. Evans, and Lung Cancer Disease Site Group of Cancer Care Onta
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
J Natl Cancer Inst, December 5, 2007; 99(23): 1753 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Kaji, H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno
11C-Acetate and 18F-Fluorodeoxyglucose Positron Emission Tomography of Pulmonary Adenocarcinoma
Ann. Thorac. Surg., January 1, 2007; 83(1): 312 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. S. Bryant and R. J. Cerfolio
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Ann. Thorac. Surg., September 1, 2006; 82(3): 1016 - 1020.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. H. Khandani and F. C. Detterbeck
Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less
J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 214 - 215.
[Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K.-i. Watanabe, H. Nomori, T. Ohtsuka, T. Naruke, A. Ebihara, H. Orikasa, K. Yamazaki, K. Uno, T. Kobayashi, and T. Goya
[F-18]Fluorodeoxyglucose Positron Emission Tomography Can Predict Pathological Tumor Stage and Proliferative Activity Determined by Ki-67 in Clinical Stage IA Lung Adenocarcinomas
Jpn. J. Clin. Oncol., July 1, 2006; 36(7): 403 - 409.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
Y. Hashimoto, T. Tsujikawa, C. Kondo, M. Maki, M. Momose, A. Nagai, T. Ohnuki, T. Nishikawa, and K. Kusakabe
Accuracy of PET for Diagnosis of Solid Pulmonary Lesions with 18F-FDG Uptake Below the Standardized Uptake Value of 2.5
J. Nucl. Med., March 1, 2006; 47(3): 426 - 431.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Bunyaviroch and R. E. Coleman
PET Evaluation of Lung Cancer
J. Nucl. Med., March 1, 2006; 47(3): 451 - 469.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Nomori, N. Kosaka, K. Watanabe, T. Ohtsuka, T. Naruke, T. Kobayashi, and K. Uno
11C-Acetate Positron Emission Tomography Imaging for Lung Adenocarcinoma 1 to 3 cm in Size With Ground-Glass Opacity Images on Computed Tomography
Ann. Thorac. Surg., December 1, 2005; 80(6): 2020 - 2025.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.